Why the study?
Does SD-3212 prevent arrhythmias in animal models compared to its enantiomer SD-3211, verapamil, and mexiletine?
Does SD-3212 prevent arrhythmias in animal models compared to its enantiomer SD-3211, verapamil, and mexiletine?
SD-3212 demonstrates dual inhibitory action on cardiac Na+ and Ca++ channels, contributing to broad antiarrhythmic properties in preclinical models.
No takes yet. Share an insight, caveat, or question.
SD-3212's preclinical profile is hypothesis-generating; leaves open translation of dual Na/Ca blockade to human arrhythmia therapy.
Miyawaki et al. (1991) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: